Longtime venture capitalist Ron Conway announced on Friday, via a post on X, that he was recently diagnosed with a rare form of cancer. He stated he will be stepping back from some of his usual activities but will continue to support founders backed by his firm, SV Angel. Conway framed this as a chance to prioritize treatments while still helping founders at inflection points, because apparently even a serious health diagnosis can be spun into a productivity hack.
He was quick to assure everyone that SV Angel will be unchanged, noting that his son, Topher Conway, has made all of their investment decisions for the better part of the last decade. For those keeping score, this means the firm's operational continuity is secured by the person who has already been running it for about ten years. He also mentioned that another son, Ronny Conway, joined as a managing partner in 2024.
Conway praised his sons, saying they bring experience from nearly every major technology cycle in Silicon Valley. Their current focus, he noted, is on partnering with founders building the future of AI, because in Silicon Valley, all roads eventually lead back to betting on artificial intelligence.
In a move that bucks the trend of oversharing, Conway said he is not revealing the specific type of cancer to avoid speculation about his prognosis, though he remains optimistic. He expressed confidence in his medical team, stating he is fortunate to have the best doctors from UCSF in San Francisco and declared, with characteristic VC fightiness, that he never backs down from a fight.